Location of Repository

Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response

By Rita Spilka, Klaus Laimer, Felix Bachmann, Gilbert Spizzo, Alexander Vogetseder, Manuel Wieser, Heimo Müller, Johannes Haybaeck and Peter Obrist


The eukaryotic translation initiation factor eIF3a is one of the core subunits of the translation initiation complex eIF3, responsible for ribosomal subunit joining and mRNA recruitment to the ribosome. It is known to play an important role in general translation initiation as well as in the specific translational regulation of various gene products, among which many influence tumour development, progression, and the therapeutically important pathways of DNA damage repair. Therefore, beyond its role in protein synthesis, eIF3a is emerging as regulator in tumour pathogenesis and therapy response and, therefore, a potential tumor marker. By means of a tissue microarray (TMA) for histopathological and statistical assessment, we here show eIF3a expression in 103 cases of squamous cell carcinoma of the oral cavity (OSCC), representing tissues from 103 independent patients. A subset of the study cohort was treated with platinum based therapy. Our results show that the 170 kDa protein is upregulated in OSCC and correlates with good overall survival. Overexpressing tumors respond better to platinum-based chemotherapy, suggesting eIF3a as a putative predictive as well as prognostic tumor marker in OSCC

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3347757
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2009). A .J e m a l ,R .S i e g e l ,E .W a r d ,Y .H a o ,J .X u ,a n dM .J .T h u n , “Cancer statistics,
    2. (2004). Carrozzo et al., “Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population,”
    3. Clinicopathological features of squamous cell carcinoma of the oral cavity in patients <40 years of age,”
    4. (1997). Cloning of a novel protein overexpressed in human mammary carcinoma,”
    5. (2010). Contemporary management of cancer of the oral cavity,”
    6. (2010). Effect of docetaxel on expression of eIF3a in human lung cancer A549 cell line,”
    7. (2011). Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating
    8. (2003). EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression,”
    9. (2011). EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis,”
    10. (2002). Estimates of the world-wide prevalence of cancer for 25 sites in the adult population,”
    11. (1988). Expression of p150 in cervical neoplasia and its potential value in predicting survival,”
    12. (2007). High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis,”
    13. (2001). Identification of a 170-kDa protein over-expressed in lung cancers,”
    14. (2007). Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells,”
    15. (2009). Inhibitors of translation initiation as cancer therapeutics,”
    16. (2010). J a c k s o n ,C .U .T .H e l l e n ,a n dT .V .P e s t o v a ,“ T h e mechanism of eukaryotic translation initiation and principles of its regulation,”
    17. (2008). Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor
    18. (2011). MTOR: from growth signal integration to cancer, diabetes and ageing,”
    19. (2010). Oral cancer: clinical features,”
    20. (2001). Oral cancer: the importance of early diagnosis and treatment,”
    21. (2010). Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer,”
    22. (1999). p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus,”
    23. (2004). p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation,”
    24. (2001). Poor dental status increases acetaldehyde production from ethanol in saliva: a possible link to increased oral cancer risk among heavy drinkers,”
    25. Reconstitution reveals the functional core of mammalian eIF3,”TheEMBOJournal,vol.26,no.14,pp.3373–3383,2007.
    26. (2010). Regulation of protein synthesis and the role of eIF3 in cancer,”
    27. (2007). Role of eIF3a (eIF3 p170) in intestinal cell differentiation and its association with early development,”
    28. (2011). Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma,”
    29. (2011). Targeting translation dependence in cancer,”
    30. (2006). The mTOR pathway in the control of protein synthesis,”
    31. (2004). The role of translation in neoplastic transformation from a pathologist’s point of view,”
    32. (2010). The translational regulator eIF3a: the tricky eIF3 subunit!,”
    33. (2011). Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments,”

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.